×
About 57,854 results

ALLMedicine™ Hepatitis C Virus Center

Research & Reviews  27,781 results

There's just not enough time: a mixed methods pilot study of hepatitis C virus screenin...
https://doi.org/10.1186/s12875-020-01327-2
BMC Family Practice; Kasting ML, Rathwell J et. al.

Dec 3rd, 2020 - Liver cancer rates are rising and hepatitis C virus (HCV) is the primary cause. The CDC recommends a one-time HCV screening for all persons born 1945-1965 (baby boomers). However, 14% of baby boomers have been screened. Few studies have examined p...

Hepatitis C virus-related vasculitis.
https://doi.org/10.1016/j.clinre.2020.11.005
Clinics and Research in Hepatology and Gastroenterology; Boleto G, Vieira M et. al.

Dec 3rd, 2020 - Cryoglobulinemic vasculitis (CryoVas) is a small-to-medium vessel systemic vasculitis caused by the deposition of mixed cryoglobulins and immune complexes. Clinical spectrum of CryoVas ranges from mild symptoms to vasculitis involving multiple org...

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A deb...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684455
World Journal of Gastroenterology; Muzica CM, Stanciu C et. al.

Dec 3rd, 2020 - Direct acting antivirals (DAAs) have revolutionized the treatment of hepatitis C virus (HCV) infection, achieving high rates (≥ 95%) of sustained virological response, with a good safety profile and high compliance rates. Consequently, it had been...

Hepatitis C: milestones from discovery to clinical cure.
https://doi.org/10.1186/s40779-020-00288-y
Military Medical Research; Hu W, Zhang C et. al.

Dec 2nd, 2020 - On October 5th, 2020, Drs. Harvey J. Alter, Michael Houghton and Charles M. Rice were rewarded with Nobel Prize in Physiology or Medicine for "the discovery of hepatitis C virus (HCV)". During the past 50 years, remarkable achievements have been m...

Eradication of hepatitis C virus infection in kidney transplant recipients using direct...
https://doi.org/10.1002/iid3.386
Immunity, Inflammation and Disease REFERENCES; Alkadi MM, Abuhelaiqa EA et. al.

Dec 2nd, 2020 - Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre-direct-acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, ...

see more →

Guidelines  47 results

EASL recommendations on treatment of hepatitis C: Final update of the series☆.
https://doi.org/10.1016/j.jhep.2020.08.018
Journal of Hepatology; , et. al.

Sep 21st, 2020 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an...

Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
https://annals.org/aim/fullarticle/2751913/prevention-diagnosis-evaluation-treatment-hepatitis-c-virus-infection-chronic-kidney

Sep 23rd, 2019 - Description: The Kidney Disease: Improving Global Outcomes (KDIGO) 2018 clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD) is an extensive updat...

FDA warns about rare occurrence of serious liver injury with use of hepatitis C medicines Mavyret, Zepatier, and Vosevi in some patients with advanced liver disease
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-rare-occurrence-serious-liver-injury-use-hepatitis-c-medicines-mavyret-zepatier-and

Aug 27th, 2019 - The Food and Drug Administration (FDA) has received reports that the use of Mavyret, Zepatier, or Vosevi to treat chronic hepatitis C in patients with moderate to severe liver impairment has resulted in rare cases of worsening liver function or li...

HIV and Viral Hepatitis - CDC
https://www.cdc.gov/hiv/pdf/library/factsheets/hiv-viral-hepatitis.pdf

Jun 26th, 2019 - People with HIV infection are affected disproportionally by viral hepatitis. Nearly 75% of people with HIV who report a history of injection drug use also are infected with hepatitis C virus (HCV).

Hepatitis C Questions and Answers for Health Professionals
https://www.cdc.gov/hepatitis/hcv/hcvfaq.htm

Apr 8th, 2019 - What are the case definitions for reportable hepatitis C virus (HCV) infections? The specific viral cause of illness cannot be determined based solely on signs, symptoms, history, or current risk factors, but must be verified by specific serologic...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  28,715 results

There's just not enough time: a mixed methods pilot study of hepatitis C virus screenin...
https://doi.org/10.1186/s12875-020-01327-2
BMC Family Practice; Kasting ML, Rathwell J et. al.

Dec 3rd, 2020 - Liver cancer rates are rising and hepatitis C virus (HCV) is the primary cause. The CDC recommends a one-time HCV screening for all persons born 1945-1965 (baby boomers). However, 14% of baby boomers have been screened. Few studies have examined p...

Hepatitis C virus-related vasculitis.
https://doi.org/10.1016/j.clinre.2020.11.005
Clinics and Research in Hepatology and Gastroenterology; Boleto G, Vieira M et. al.

Dec 3rd, 2020 - Cryoglobulinemic vasculitis (CryoVas) is a small-to-medium vessel systemic vasculitis caused by the deposition of mixed cryoglobulins and immune complexes. Clinical spectrum of CryoVas ranges from mild symptoms to vasculitis involving multiple org...

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A deb...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684455
World Journal of Gastroenterology; Muzica CM, Stanciu C et. al.

Dec 3rd, 2020 - Direct acting antivirals (DAAs) have revolutionized the treatment of hepatitis C virus (HCV) infection, achieving high rates (≥ 95%) of sustained virological response, with a good safety profile and high compliance rates. Consequently, it had been...

Hepatitis C: milestones from discovery to clinical cure.
https://doi.org/10.1186/s40779-020-00288-y
Military Medical Research; Hu W, Zhang C et. al.

Dec 2nd, 2020 - On October 5th, 2020, Drs. Harvey J. Alter, Michael Houghton and Charles M. Rice were rewarded with Nobel Prize in Physiology or Medicine for "the discovery of hepatitis C virus (HCV)". During the past 50 years, remarkable achievements have been m...

Eradication of hepatitis C virus infection in kidney transplant recipients using direct...
https://doi.org/10.1002/iid3.386
Immunity, Inflammation and Disease REFERENCES; Alkadi MM, Abuhelaiqa EA et. al.

Dec 2nd, 2020 - Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre-direct-acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor tolerance, ...

see more →

News  1,275 results

Patients Cured of HCV Still at High Liver Cancer Risk
https://www.medscape.com/viewarticle/941615

Nov 25th, 2020 - NEW YORK (Reuters Health) - The burden of hepatocellular carcinoma (HCC) appears likely to move from patients who currently have hepatitis C virus (HCV) infection to those who have previously been cured, a new modeling study suggests. "The new hep...

Combo DAA Treatments May Benefit Patients With Resistant HCV Genotype 3
https://www.medscape.com/viewarticle/941464

Nov 22nd, 2020 - Patients with hepatitis C virus (HCV) genotype 3 infection have shown resistance to direct-acting antiviral (DAA) treatments. However, a meta-analysis of 34 research reports found that DAA combo treatment can be effective in achieving sustained vi...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.staging.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

Opt-Out Policy at a Syringe Service Program Increased HIV/HCV Testing
https://www.medscape.com/viewarticle/941269

Nov 18th, 2020 - Bundled opt-out HIV/hepatitis C virus (HCV) testing increased the percentage of syringe service program (SSP) clients who received HIV and HCV rapid tests at enrollment into the program. Researchers conducted a retrospective comparative analysis o...

Vanquishing Hepatitis C: A Remarkable Success Story
https://www.staging.medscape.com/viewarticle/940796

Nov 16th, 2020 - In celebration of Medscape's 25th birthday, we are highlighting key breakthroughs that have defined the last quarter century of medicine, as chosen by experts in their respective fields. One of the most remarkable stories in medicine must be the r...

see more →

Patient Education  3 results see all →